atorvastatin has been researched along with bilirubin in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Ceppa, P; Indiveri, F; Pelli, N; Setti, M; Toncini, C | 1 |
Hsu, M; Morioka, I; Muchova, L; Schröder, H; Stevenson, DK; Vitek, L; Wong, RJ; Zelenka, J | 1 |
Ali, F; Boyle, JJ; Hamdulay, SS; Haskard, DO; Kinderlerer, AR; Lidington, EA; Mason, JC; Randi, AM; Soares, MP; Yamaguchi, T | 1 |
Augustin, S; Esteban, R; Ezkurdia, N; Genescà, J; Martell, M; Raurell, I; Rodríguez, S | 1 |
Elisaf, M; Kei, A; Liberopoulos, E; Tellis, C; Tselepis, A | 1 |
Bátai-Konczos, A; Jemnitz, K; Kékesi, O; Kis, E; Szabó, K; Szabó, M; Veres, Z | 1 |
Cerne, D; Hallstroem, S; Jürgens, G; Marc, J; Mirjanic-Azaric, B; Rizzo, M; Srdic, S | 1 |
Du, M; Wang, Q; Wang, T; Zhu, S | 1 |
2 trial(s) available for atorvastatin and bilirubin
Article | Year |
---|---|
Effect of switch to the highest dose of rosuvastatin versus add-on-statin fenofibrate versus add-on-statin nicotinic acid/laropiprant on oxidative stress markers in patients with mixed dyslipidemia.
Topics: Aged; Apolipoprotein B-100; Atorvastatin; Bilirubin; Biomarkers; Dinoprost; Drug Therapy, Combination; Dyslipidemias; Female; Fenofibrate; Fluorobenzenes; Greece; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Indoles; Lipoproteins, LDL; Male; Middle Aged; Niacin; Oxidative Stress; Prospective Studies; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Time Factors; Treatment Outcome; Uric Acid | 2014 |
[Optimization of long-term hypolipidemia treatment of patients with myocardial infarction in combination with non-alcoholic steatohepatitis].
Topics: Atorvastatin; Bilirubin; Fluorobenzenes; Heptanoic Acids; Humans; Hypolipidemic Agents; Lipids; Liver; Middle Aged; Myocardial Infarction; Non-alcoholic Fatty Liver Disease; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides; Transaminases; Triglycerides; Ursodeoxycholic Acid | 2014 |
7 other study(ies) available for atorvastatin and bilirubin
Article | Year |
---|---|
Autoimmune hepatitis revealed by atorvastatin.
Topics: Aged; Alanine Transaminase; Aspartate Aminotransferases; Atorvastatin; Autoimmune Diseases; Bilirubin; Chemical and Drug Induced Liver Injury; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Liver Function Tests; Pyrroles | 2003 |
Statin treatment increases formation of carbon monoxide and bilirubin in mice: a novel mechanism of in vivo antioxidant protection.
Topics: Animals; Antioxidants; Atorvastatin; Bilirubin; Carbon Monoxide; Carboxyhemoglobin; Fluorobenzenes; Heme Oxygenase (Decyclizing); Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Peroxidation; Liver Function Tests; Mice; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides | 2007 |
Statin-mediated cytoprotection of human vascular endothelial cells: a role for Kruppel-like factor 2-dependent induction of heme oxygenase-1.
Topics: Antioxidants; Atorvastatin; Bilirubin; Biliverdine; Cell Survival; Cells, Cultured; Cytoprotection; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Induction; Enzyme Inhibitors; Ferritins; Heme Oxygenase-1; Heptanoic Acids; Humans; Hydrogen Peroxide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iron Chelating Agents; Kruppel-Like Transcription Factors; Mevalonic Acid; Oxidants; Oxidative Stress; Prenylation; Promoter Regions, Genetic; Protoporphyrins; Pyrroles; Reactive Oxygen Species; RNA Interference; RNA, Messenger; RNA, Small Interfering; Terpenes | 2007 |
The renal effects of droxidopa are maintained in propranolol treated cirrhotic rats.
Topics: Adrenergic beta-Antagonists; Animals; Atorvastatin; Bilirubin; Carbazoles; Carvedilol; Creatinine; Droxidopa; Drug Evaluation, Preclinical; Drug Therapy, Combination; Hemodynamics; Heptanoic Acids; Liver Cirrhosis, Experimental; Mesenteric Artery, Superior; Osmolar Concentration; Portal Pressure; Potassium; Propanolamines; Propranolol; Pyrroles; Rats; Serum Albumin; Sodium; Vascular Resistance | 2015 |
Statins alter the hepatobiliary transport of unconjugated and conjugated bilirubin in sandwich-cultured rat hepatocytes.
Topics: Animals; Atorvastatin; ATP-Binding Cassette Transporters; Bilirubin; Biological Transport; Cell Culture Techniques; Cells, Cultured; Fatty Acids, Monounsaturated; Fluorobenzenes; Fluvastatin; Hepatocytes; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Multidrug Resistance-Associated Proteins; Organic Anion Transporters; Pravastatin; Pyrimidines; Pyrroles; Rats; Rosuvastatin Calcium; Sulfonamides | 2014 |
Atorvastatin treatment increases plasma bilirubin but not HMOX1 expression in stable angina patients.
Topics: Angina, Stable; Atorvastatin; Bilirubin; Female; Gene Expression Regulation, Enzymologic; Heme Oxygenase-1; Humans; Male; Middle Aged; Proteolysis; RNA, Messenger | 2015 |
Application of Atorvastatin Combined with Ezetimibe in Elderly Patients with Hypertension Combined with T2DM and Analysis of Significance of Changes in Serum Bilirubin Levels During Treatment.
Topics: Aged; Atorvastatin; Bilirubin; Diabetes Mellitus, Type 2; Ezetimibe; Glucose; Humans; Hypertension | 2023 |